SCHEMBL28103281

SCHEMBL28103281

CCCC(N)c1ccc(OCC)c(OCC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
LMNA P02545 2/20 0.44
TNF P01375 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
SLC2A1 P11166 1/20 0.40
HTT P42858 1/20 0.39
MAPK1 P28482 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623386 0.87 ALDH1A1 (0.48) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL28103052 0.85 LMNA (0.40) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL2999171 0.81 TP53 (0.47) ALDH1A1LMNAKDM4EMAPTGAA
SCHEMBL13981506 0.81 ACHE (0.47) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL28103261 0.81 ACHE (0.47) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL10361478 0.80 ALDH1A1 (0.48) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL2997838 0.80 MAPT (0.50) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL2990146 0.80 PDE4A (0.46) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL1827890 0.80 PDE4A (0.46) ALDH1A1LMNATNFKDM4EMAPT
SCHEMBL7099805 0.79 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105899508-B Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2017-07-04 CN disclosed
CN-105899508-A Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection 豪夫迈·罗氏有限公司 2016-08-24 CN disclosed